Preclinical modeling has demonstrated its importance in recruiting CD8+ T cells to the tumor microenvironment via CCL5, CXCL9, and CDCL10 chemokine release (Carretero et al., 2015; Varricchi et al., 2017). The gene discussed is CD8A; the disease is neoplasm.